Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invyncible vs RxSpan MD

Invyncible
Site position #281

Lower grade

vs+20.7
RxSpan MD
Site position #6

Higher grade

The verdict

RxSpan MD takes it — 84.3/100 to 63.6/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD offers compounded injections, oral options and a brand-name lane, with regular monthly pricing alongside discounted prepaid plans that require a closer look at renewal and refund terms.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRxSpan MD +41
45
86
Dose & formulationRxSpan MD +11
78
89
Clinical oversightRxSpan MD +18
70
88
Labs & monitoringRxSpan MD +31
52
83
FulfillmentRxSpan MD +16
73
89
Contract termsInvyncible +24
77
53
Invyncible · left barRxSpan MD · right bar

The numbers

MetricInvyncibleRxSpan MD
WeighScore63.6/10084.3/100
GradeCB
Site position#281#6
Semaglutide$149 starter program; supply length and refill cost need confirmation$249/mo month-to-month ($219 on three months, $199 on six, $194 on twelve)
Tirzepatide$180 per 4-week starter program (2.5 mg weekly, compounded glycine + B12)$329/mo month-to-month ($309 on three months, $289 on six, $269 on twelve)
CoverageVaries by formulation; glycine/B12 programs exclude AR, CA, IN, MN, OR and SCConfirm treatment availability during intake
Brand-name accessYesYes
Oral / sublingualYesYes
Invyncible

Site position #281 · C

Strengths

  • Six pharmacies named with contact details
  • Patients can request a prescription copy or nominate a pharmacy
  • Public catalogs distinguish compounded products, brands and oral options
  • Refills are not automatic; payment is finalized only after physician approval

Where it loses points

  • Program amounts are not universal monthly prices; dose and formulation can change cost
  • Shipping cost not established on the reviewed program pages
  • State exclusions differ by formulation
  • Compounded medications are not FDA-approved
RxSpan MD

Site position #6 · B

Strengths

  • Public catalog offers compounded injections, oral options and brand-name programs
  • Regular monthly injection pricing of $249 semaglutide and $329 tirzepatide
  • Catalog states consultation, medication, supplies, shipping and support are included
  • Names physician founder Dr. John Diaz and describes licensed-physician review

Where it loses points

  • Lowest advertised monthly equivalents require prepaid terms and a promotional code
  • Annual promotions automatically renew
  • Public terms do not establish a refund schedule for unused prepaid treatment
  • Compounded semaglutide and tirzepatide are not FDA-approved

Featured provider

RxSpan MD

RxSpan MD scores 84.3/100 (B). RxSpan MD offers compounded injections, oral options and a brand-name lane, with regular monthly pricing alongside discounted prepaid plans that require a closer look at renewal and refund terms.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard